期刊文献+

脑瘤显像剂I-AMT的标记及动物实验 被引量:1

Preparation of an imaging agent for brain tumour-radioiodinated α-methyl-1-tyrosine(AMT) and its animal studies
下载PDF
导出
摘要 探讨了α-甲基-1-酷氨酸(α-methyl-l-tyrosine简称AMT)的放射性碘标记、分离纯化方法及其在小白鼠体内的分布。结果显示:采用氯胺-T法或Iodogen法标记,其标记率最低为60%,最高达80%以上。采用SephadexLH-20柱层析分离I-AMT,其放化纯度均大于98%。I-AMT从血中清除迅速,主要经肾脏排泄;静注给药后5、15、30、60min。 Radioiodinated AMT is a new positive imaging agent for brain tumour. In this paper, its radioiodination, purification, and biodistribution in mice is described. AMT was labelled with 125I/131I using either chloramine-T or iodogen method. The labelling rate was 60% to 80%. After column chromatography on sephadex LH-20, the radiochemical purity was greater than 98%. Animal experiments showed that 25I-AMT was eliminated from blood rapidly and was mainly excreted through kidney. 5, 15, 30, 60 minutes after tail vein injection, the radioactivities of brain tissue per gram was 4.14%, 2.50%, 2.13%, 1.24% of injection dose respectively.
出处 《核技术》 CAS CSCD 北大核心 1993年第11期669-673,共5页 Nuclear Techniques
关键词 AMT 脑肿瘤 标记化合物 Radioiodination Brain tumour
  • 相关文献

参考文献1

  • 1B. Bubeck,M. Eisenhut,U. Heimke,K. zum Winkel. Melanoma affine radiopharmaceuticals[J] 1981,European Journal of Nuclear Medicine(5):227~233

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部